UBS Group’s Alto Ingredients ALTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$631K Buy
130,449
+119,964
+1,144% +$381K ﹤0.01% 5906
2025
Q4
$30.2K Buy
10,485
+7,580
+261% +$14.3K ﹤0.01% 7528
2025
Q3
$3.14K Buy
2,905
+485
+20% +$545 ﹤0.01% 9081
2025
Q2
$2.78K Sell
2,420
-23,983
-91% -$23K ﹤0.01% 9422
2025
Q1
$30.1K Sell
26,403
-12,519
-32% -$19.4K ﹤0.01% 7941
2024
Q4
$60.7K Buy
38,922
+26,941
+225% +$42.2K ﹤0.01% 7178
2024
Q3
$19.3K Hold
11,981
﹤0.01% 7395
2024
Q2
$17.3K Sell
11,981
-9,622
-45% -$16.6K ﹤0.01% 7394
2024
Q1
$47.1K Buy
21,603
+20,951
+3,213% +$44.2K ﹤0.01% 6535
2023
Q4
$1.73K Sell
652
-250
-28% -$796 ﹤0.01% 8233
2023
Q3
$3.99K Sell
902
-6,041
-87% -$23.3K ﹤0.01% 7495
2023
Q2
$20.1K Sell
6,943
-22,725
-77% -$43.3K ﹤0.01% 6865
2023
Q1
$44.5K Sell
29,668
-13,554
-31% -$37.1K ﹤0.01% 6546
2022
Q4
$124K Buy
43,222
+32,726
+312% +$116K ﹤0.01% 5901
2022
Q3
$38K Sell
10,496
-137,939
-93% -$581K ﹤0.01% 6605
2022
Q2
$550K Sell
148,435
-5,986
-4% -$31.3K ﹤0.01% 4200
2022
Q1
$1.05M Sell
154,421
-47,269
-23% -$265K ﹤0.01% 4045
2021
Q4
$970K Sell
201,690
-44,253
-18% -$232K ﹤0.01% 4416
2021
Q3
$1.22M Buy
245,943
+240,567
+4,475% +$1.21M ﹤0.01% 4016
2021
Q2
$33K Sell
5,376
-436,507
-99% -$2.54M ﹤0.01% 6823
2021
Q1
$2.4M Buy
441,883
+434,827
+6,163% +$2.88M ﹤0.01% 3377
2020
Q4
$38K Buy
7,056
+7,034
+31,973% +$48.8K ﹤0.01% 6414
2020
Q3
$0 Sell
22
-15,335
-100% -$53.1K ﹤0.01% 7947
2020
Q2
$11K Buy
15,357
+14,665
+2,119% +$7.39K ﹤0.01% 6936
2020
Q1
$0 Sell
692
-11,596
-94% -$6.1K ﹤0.01% 7927
2019
Q4
$8K Buy
12,288
+11,596
+1,676% +$6.57K ﹤0.01% 7378
2019
Q3
$0 Buy
692
+3
+0.4% +$2 ﹤0.01% 7964
2019
Q2
$1K Sell
689
-150
-18% -$153 ﹤0.01% 7698
2019
Q1
$1K Sell
839
-1,005
-55% -$1.18K ﹤0.01% 7519
2018
Q4
$2K Sell
1,844
-3,966
-68% -$6.55K ﹤0.01% 7784
2018
Q3
$11K Buy
5,810
+5,312
+1,067% +$11.9K ﹤0.01% 7106
2018
Q2
$1K Buy
498
+446
+858% +$1.42K ﹤0.01% 7801
2018
Q1
$0 Sell
52
-6,387
-99% -$25.5K ﹤0.01% 7777
2017
Q4
$29K Buy
6,439
+2,969
+86% +$14.1K ﹤0.01% 6255
2017
Q3
$19K Buy
3,470
+2,945
+561% +$16.1K ﹤0.01% 6481
2017
Q2
$3K Sell
525
-374
-42% -$2.43K ﹤0.01% 7276
2017
Q1
$6K Sell
899
-7,000
-89% -$53.3K ﹤0.01% 6877
2016
Q4
$75K Buy
7,899
+6,754
+590% +$54.3K ﹤0.01% 5497
2016
Q3
$8K Sell
1,145
-7,030
-86% -$45.3K ﹤0.01% 6896
2016
Q2
$44K Sell
8,175
-118,223
-94% -$587K ﹤0.01% 5609
2016
Q1
$592K Buy
126,398
+108,187
+594% +$425K ﹤0.01% 3647
2015
Q4
$87K Buy
18,211
+16,639
+1,058% +$87K ﹤0.01% 5326
2015
Q3
$10K Sell
1,572
-6,513
-81% -$49.7K ﹤0.01% 7253
2015
Q2
$83K Buy
8,085
+8,076
+89,733% +$93.1K ﹤0.01% 5560
2015
Q1
$0 Sell
9
-14,466
-100% -$139K ﹤0.01% 8747
2014
Q4
$149K Buy
+14,475
New +$177K ﹤0.01% 5312

Other funds holding ALTO

UBS Group's ALTO Position: Q1 2026 in Review

UBS Group increased its Alto Ingredients (ALTO) stake by 1,144% in Q1 2026, buying an estimated $381K and bringing the position to 130,449 shares worth $631K. The position accounts for ﹤0.01% of the portfolio, ranked #5906.

UBS Group first reported a position in ALTO in Q4 2014 and has held it in 46 quarters since. The position peaked at $2.4M in Q1 2021. 102 funds tracked by Wall St. Rank hold ALTO as of Q1 2026.

  • UBS Group held 130,449 shares of Alto Ingredients worth $631K as of Q1 2026.
  • UBS Group bought 119,964 Alto Ingredients shares in Q1 2026, an estimated $381K.
  • Alto Ingredients made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5906 holding.
  • UBS Group first reported a position in Alto Ingredients in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Alto Ingredients position peaked at $2.4M in Q1 2021.
  • 102 funds tracked by Wall St. Rank held Alto Ingredients as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.